BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

605 related articles for article (PubMed ID: 7479848)

  • 1. Stimulation-dependent I kappa B alpha phosphorylation marks the NF-kappa B inhibitor for degradation via the ubiquitin-proteasome pathway.
    Alkalay I; Yaron A; Hatzubai A; Orian A; Ciechanover A; Ben-Neriah Y
    Proc Natl Acad Sci U S A; 1995 Nov; 92(23):10599-603. PubMed ID: 7479848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The ubiquitin-proteasome pathway is required for processing the NF-kappa B1 precursor protein and the activation of NF-kappa B.
    Palombella VJ; Rando OJ; Goldberg AL; Maniatis T
    Cell; 1994 Sep; 78(5):773-85. PubMed ID: 8087845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inactivation of NF-kappa B inhibitor I kappa B alpha: ubiquitin-dependent proteolysis and its degradation product.
    Li CC; Dai RM; Longo DL
    Biochem Biophys Res Commun; 1995 Oct; 215(1):292-301. PubMed ID: 7575604
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of NF-kappa-B cellular function via specific targeting of the I-kappa-B-ubiquitin ligase.
    Yaron A; Gonen H; Alkalay I; Hatzubai A; Jung S; Beyth S; Mercurio F; Manning AM; Ciechanover A; Ben-Neriah Y
    EMBO J; 1997 Nov; 16(21):6486-94. PubMed ID: 9351830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.
    Chen Z; Hagler J; Palombella VJ; Melandri F; Scherer D; Ballard D; Maniatis T
    Genes Dev; 1995 Jul; 9(13):1586-97. PubMed ID: 7628694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Appearance of apparently ubiquitin-conjugated I kappa B-alpha during its phosphorylation-induced degradation in intact cells.
    Traenckner EB; Baeuerle PA
    J Cell Sci Suppl; 1995; 19():79-84. PubMed ID: 8655651
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis mediated by cytosolic m-calpain. A mechanism parallel to the ubiquitin-proteasome pathway for nuclear factor-kappab activation.
    Han Y; Weinman S; Boldogh I; Walker RK; Brasier AR
    J Biol Chem; 1999 Jan; 274(2):787-94. PubMed ID: 9873017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IkappaBalpha ubiquitination in signal-induced activation of NFkappaB in vivo.
    Roff M; Thompson J; Rodriguez MS; Jacque JM; Baleux F; Arenzana-Seisdedos F; Hay RT
    J Biol Chem; 1996 Mar; 271(13):7844-50. PubMed ID: 8631829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel in vitro assay for deubiquitination of I kappa B alpha.
    Strayhorn WD; Wadzinski BE
    Arch Biochem Biophys; 2002 Apr; 400(1):76-84. PubMed ID: 11913973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of ubiquitin-proteasome pathway-mediated I kappa B alpha degradation by a naturally occurring antibacterial peptide.
    Gao Y; Lecker S; Post MJ; Hietaranta AJ; Li J; Volk R; Li M; Sato K; Saluja AK; Steer ML; Goldberg AL; Simons M
    J Clin Invest; 2000 Aug; 106(3):439-48. PubMed ID: 10930447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of NF-kappa B/Rel by Tax involves degradation of I kappa B alpha and is blocked by a proteasome inhibitor.
    Maggirwar SB; Harhaj E; Sun SC
    Oncogene; 1995 Sep; 11(5):993-8. PubMed ID: 7675460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of NF-kappa B by phosphatase inhibitors involves the phosphorylation of I kappa B alpha at phosphatase 2A-sensitive sites.
    Sun SC; Maggirwar SB; Harhaj E
    J Biol Chem; 1995 Aug; 270(31):18347-51. PubMed ID: 7629157
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Signal-induced degradation of I(kappa)B(alpha): association with NF-kappaB and the PEST sequence in I(kappa)B(alpha) are not required.
    Van Antwerp DJ; Verma IM
    Mol Cell Biol; 1996 Nov; 16(11):6037-45. PubMed ID: 8887633
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SCF(beta-TRCP) and phosphorylation dependent ubiquitinationof I kappa B alpha catalyzed by Ubc3 and Ubc4.
    Strack P; Caligiuri M; Pelletier M; Boisclair M; Theodoras A; Beer-Romero P; Glass S; Parsons T; Copeland RA; Auger KR; Benfield P; Brizuela L; Rolfe M
    Oncogene; 2000 Jul; 19(31):3529-36. PubMed ID: 10918611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of lysine residues required for signal-induced ubiquitination and degradation of I kappa B-alpha in vivo.
    Rodriguez MS; Wright J; Thompson J; Thomas D; Baleux F; Virelizier JL; Hay RT; Arenzana-Seisdedos F
    Oncogene; 1996 Jun; 12(11):2425-35. PubMed ID: 8649784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo and in vitro recruitment of an IkappaBalpha-ubiquitin ligase to IkappaBalpha phosphorylated by IKK, leading to ubiquitination.
    Suzuki H; Chiba T; Kobayashi M; Takeuchi M; Furuichi K; Tanaka K
    Biochem Biophys Res Commun; 1999 Mar; 256(1):121-6. PubMed ID: 10066434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphorylation of I kappa B alpha precedes but is not sufficient for its dissociation from NF-kappa B.
    DiDonato JA; Mercurio F; Karin M
    Mol Cell Biol; 1995 Mar; 15(3):1302-11. PubMed ID: 7862124
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different mechanisms control signal-induced degradation and basal turnover of the NF-kappaB inhibitor IkappaB alpha in vivo.
    Krappmann D; Wulczyn FG; Scheidereit C
    EMBO J; 1996 Dec; 15(23):6716-26. PubMed ID: 8978697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signal-induced degradation of I kappa B alpha requires site-specific ubiquitination.
    Scherer DC; Brockman JA; Chen Z; Maniatis T; Ballard DW
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):11259-63. PubMed ID: 7479976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SUMO-1 modification of IkappaBalpha inhibits NF-kappaB activation.
    Desterro JM; Rodriguez MS; Hay RT
    Mol Cell; 1998 Aug; 2(2):233-9. PubMed ID: 9734360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.